British Journal of Haematology

Cover image for British Journal of Haematology

October 1992

Volume 82, Issue 2

Pages 287–482

    1. Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c-kit (pages 287–294)

      Herbert Strobl, Masafumi Takimoto, Otto Majdic, Paul Höcker and Walter Knapp

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06420.x

    2. Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia (pages 295–301)

      Johanna W. Baars, Jan Paul de Boer, John Wagstaff, Dorina Roem, Anke J. M. Eerenberg-Belmer, Jos Nauta, Herbert M. Pinedo and C. Erik Hack

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06421.x

    3. Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro (pages 302–309)

      Adrienne L. Morey and Kenneth A. Fleming

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06422.x

    4. Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503 (pages 310–316)

      O. B. Eden, I. Hann, J. Imeson, S. Cotterill, M. Gerrard and C. R. Pinkerton

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06423.x

    5. Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trial (pages 317–323)

      A. Khwaja, D. C. Linch, A. H. Goldstone, R. Chopra, R. E. Marcus, J. Z. Wimperis, N. H. Russell, A. P. Haynes, D. W. Milligan, M. J. Leyland, D. A. Winfield, B. W. Hancock, A. Newland, S. T. Dürrant, S. Devereux, S. Roitt, M. Collins and G. Vaughan Hudson

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06424.x

    6. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations (pages 324–331)

      Elisabeth Paietta, Brian Van Ness, John Bennett, Janis Racevskis, Rasim Gucalp, Peter Cassileth and Peter H. Wiernik

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06425.x

    7. Re-emergence in remission of primary clone in acute myelogenous leukaemias with multiple chromosomal aberrations at diagnosis (pages 332–336)

      Sverre Heim, Anne-Grethe Sørensen, Bjarne Egelund Christensen and Niels Tinggaard Pedersen

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06426.x

    8. The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study (pages 337–346)

      Richard A. Larson, Roger S. Day, Nozar Azarnia, John M. Bennett, George Browman, Jack Goldberg, Arlan Gottlieb, Hans Grunwald, Kenneth Miller, Azra Raza, Ralph Vogler, Elliot Winton and Harvey D. Preisler

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06427.x

    9. Primary myelodysplastic syndrome in children: the clinical experience in 33 cases (pages 347–353)

      M. A. Tuncer, A. Pagliuca, G. Hicsonmez, S. Yetgin, S. Ozsoylu and G. J. Mufti

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06428.x

    10. Low-dose etoposide: a potential therapy for myelodysplastic syndromes (pages 354–357)

      K. Ogata, T. Yamada, T. Ito, S. Gomi, Y. Tanabe, I. Ohki, K. Dan and T. Nomura

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06429.x

    11. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes (pages 358–367)

      C. Aul, N. Gattermann and W. Schneider

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06430.x

    12. Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies (pages 368–373)

      Tomoko Hara, Ayako Kojima, Hiroko Fukuda, Toru Masaoka, Yasuo Fukumori, Misako Matsumoto and Tsukasa Seya

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06431.x

    13. Cellular and humoral immune responses in haemophiliacs after vaccination against tick-borne encephalitis (pages 374–383)

      Hermann M. Wolf, Martina Pum, Rita Jáger, Lajos István, Josef W. Mannhalter and Martha M. Eibl

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06432.x

    14. Treatment of haemophilia flexion deformities using the Flowtron intermittent compression system (pages 384–387)

      P. Yates, J. Cornwell, G. L. Scott and R. M. Atkins

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06433.x

    15. Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma (pages 388–390)

      Marco Cattaneo, Donato Bettega, Rossana Lombardi, Anna Lecchi and Pier Mannuccio Mannucci

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06434.x

    16. The low molecular weight heparin Enoxaparin inhibits the consumption of factor VII and prothrombin activation in vivo associated with elective knee replacement surgery (pages 391–399)

      Frederick A. Orosu, Jacques Leclerc, Fernand Delorme, Sharon Craven, Shamiran Shafai, Lori Frewin and Morris A. Blajchman

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06435.x

    17. Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent (pages 400–405)

      F. A. Ofosu, M. Levine, S. Craven, L. Dewar, S. Shafai and M. A. Blajchman

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06436.x

    18. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4) (pages 406–413)

      Ana Padilla, Elaine Gray, Duncan S. Pepper and Trevor W. Barrowcliffe

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06437.x

    19. A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency (pages 414–416)

      Birgitta Seiving, Per Henriksson, Pål Stenberg and Inga Marie Nilsson

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06438.x

    20. The 32·6 kb Indian δβ-thalassaemia deletion ends in a 3·4 kb L1 element downstream of the β-globin gene (pages 417–421)

      J. G. Gilman, E. C. Brinson and N. Mishima

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06439.x

    21. Haemoglobin F levels in sudden infant deaths (pages 422–430)

      D. G. Pagan and A. Walker

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06440.x

    22. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1 (pages 431–436)

      F. N. Al-Refaie, D. G. Wickens, B. Wonke, G. J. Kontoghiorghes and A. V. Hoffbrand

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06441.x

    23. Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: evidence for donor origin of the antibody producing cells (pages 437–444)

      J. Labadie, M. J. D. van Tol, N. H. Dijkstra, M. van der Kaaden, C. M. Jol van der Zijde, G. G. de Lange, F. E. Zwaan and J. M. Vossen

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06442.x

    24. Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores (pages 445–454)

      R. T. Hughes, T. Smith, R. Hesp, B. Hulme, D. C. Dukes, M. B. Bending, J. Pearson, K. B. Raja, P. Mary Cotes and M. J. Pippard

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06443.x

    25. Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial (pages 460–466)

      M. B. Agarwal, S. S. Gupte, C. Viswanathan, D. Vasandani, J. Ramanathan, Neena Desai, R. R. Puniyani and A. T. Chhablani

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06445.x

    26. Towards a new predictor of AIDS progression through the quantisation of HIV-1 DNA copies by PCR in HIV-infected individuals (pages 467–471)

      Jean-Jacques Lefrère, Martine Mariotti, Eric Wattel, Francois Lefrère, Geneviève Inchauspe, Dominique Costagliola and Alfred Prince

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06446.x

  1. Case Reports

    1. Top of page
    2. Case Reports
    3. Correspondence
    1. THERAPY WITH RECOMBINANT INTERFERON ALPHA-2c DURING UNEXPECTED PREGNANCY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA (pages 472–473)

      Romeo P. Reichel, Werner Linkesch and Doris Schetitska

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06447.x

    2. TRANSLOCATION (3;21)(q26–2;q22–1) FOUND IN A PATIENT WITH MYELODYSPLASTIC SYNDROME AND LONG-TERM EXPOSURE TO ORGANIC SOLVENTS (pages 473–475)

      Taizo Tasaka, Masami Nagai, Kazunori Sasaki, Michio Murata, Teruhisa Taoka, Kazuma Ikeda, Terukazu Tanaka, Tatsiio Abe, Jiro Takahara and Shozo Irino

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06448.x

    3. TRANSIENT PLASMACYTOSIS WITH ACUTE INFECTION IN MYELOMA (page 475)

      Kayoko Murayama, Morio Sawamura and Kousei Tamura

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06449.x

    4. MYELODYSPLASTIC SYNDROME ASSOCIATED WITH INCREASED BONE MARROW FIBROSIS AND TRANSLOCATION (5;12)(q33:p12·3) (pages 476–477)

      Roberto Lerza, Giorgio Castello, Mario Sessarego, Donatella Cavallini and Ivo Pannacciulli

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06450.x

    5. SPONTANEOUS REGRESSION OF Ki-1 POSITIVE T-CELL NON-HODGKIN'S LYMPHOMA IN A PATIENT WITH HIV INFECTION (pages 477–478)

      M. J. M. Diekman, P. Bresser, L. A. Noorduyn and P. Reiss

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06451.x

  2. Correspondence

    1. Top of page
    2. Case Reports
    3. Correspondence
    1. You have free access to this content
      PROGNOSTIC IRRELEVANCE OF CD34 IN ACUTE MYELOID LEUKAEMIA (pages 479–480)

      C. Selleri, R. Notaro, L. Catalano, R. Fontana, L. Del Vecchio and B. Rotoli

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06452.x

    2. You have free access to this content
      PROGNOSTIC IRRELEVANCE OF CD34 IN ACUTE MYELOID LEUKAEMIA (pages 480–481)

      Robert B. Geller

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06454.x

    3. You have free access to this content
      PROGNOSTIC IRRELEVANCE OF CD34 IN ACUTE MYELOID LEUKAEMIA (page 480)

      María Guinot, Guillermo F. Sanz, Amparo Sempere, María J. Arilla, Isidro Jarque, Federico Gomis and Miguel A. Sanz

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06453.x

    4. You have free access to this content
      SPLENECTOMY AND CHRONIC ITP IN CHILDREN (pages 481–482)

      M. M. Reid

      Version of Record online: 12 MAR 2008 | DOI: 10.1111/j.1365-2141.1992.tb06455.x

SEARCH

SEARCH BY CITATION